Asif Ali

Chief Financial Officer · Protagonist Therapeutics

Asif Ali (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $8.3M of PTGX (58,629 sh across 2 lots, as filed), executed Sep 30. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.6M

shares × price, as filed

Last traded

Sep 30

Filed Oct 2

Median ADV $107.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $17.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

PTGX

Protagonist Therapeutics, Inc. PTGX · 0 buys · 6 sells 6 filings

Recent filings

PTGXSALE Protagonist Therapeutics, Inc. View filing → $8.3M
58,629 sh across 2 lots
Exec Sep 30
Filed Oct 2 · 4:10 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $185K
1,750 sh × $105.47
Exec Apr 20
Filed Apr 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $2.6M
24,765 sh × $104.24
Exec Mar 26
Filed Mar 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $3.8M
46,203 sh across 2 lots
Exec Jan 27
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $708K
8,588 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $1.5M
24,903 sh × $58.73
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET